Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Domenico Lepore

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Eye (London, England)|January 20, 2021
Early angiographic signs of retinopathy of prematurity requiring treatmentDomenico Lepore, Marco H Ji, Gui-Shuang Ying, et al.
Italian Journal of Pediatrics|March 13, 2021
Incidence and risk factors of retinopathy of prematurity in an Italian cohort of preterm infantsCarlo Dani, Caterina Coviello, Fiorenza Panin, et al.
Seminars in Ophthalmology|March 19, 2024
Taser-Related Ocular Injuries: A Review of the Literature and Medico-Legal ImplicationsGiovanni Aulino, Federico Giannuzzi, Matteo Mario Carlà, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|March 27, 2020
Functional and Morphologic Findings at Four Years After Intravitreal Bevacizumab or Laser for Type 1 ROPDomenico Lepore, Marco H Ji, Graham E Quinn, et al.
International Journal of Legal Medicine|January 24, 2022
The role of retinal imaging in the management of abusive head trauma casesAntonio Oliva, Simone Grassi, Francesca Cazzato, et al.
Journal of Pediatric Ophthalmology and Strabismus|September 30, 2010
Effectiveness of ketorolac tromethamine in prevention of severe retinopathy of prematurityCarmen Giannantonio, Patrizia Papacci, Velia Purcaro, et al.
The Lancet. Child & Adolescent Health|August 15, 2021
2-year outcomes of ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW extension study): prospective follow-up of an open label, randomised controlled trialNeil Marlow, Andreas Stahl, Domenico Lepore, et al.
Journal of Applied Biomaterials & Functional Materials|February 7, 2017
Effect of topical antiinflammatory drugs on mechanical behavior of rabbit corneaDomenico Lepore, Roberto De Santis, Monica M Pagliara, et al.
Paediatric Anaesthesia|December 21, 2013
Phenylephrine eye drops in pediatric patients undergoing ophthalmic surgery: incidence, presentation, and management of complications during general anesthesiaFabio Sbaraglia, Nadia Mores, Rossella Garra, et al.
Ophthalmology. Retina|February 24, 2022
Time Course of Retinopathy of Prematurity Regression and Reactivation After Treatment with Ranibizumab or Laser in the RAINBOW TrialBrian W Fleck, James D Reynolds, Qi Zhu, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Eye (London, England)|January 20, 2021
Early angiographic signs of retinopathy of prematurity requiring treatmentDomenico Lepore, Marco H Ji, Gui-Shuang Ying, et al.
Italian Journal of Pediatrics|March 13, 2021
Incidence and risk factors of retinopathy of prematurity in an Italian cohort of preterm infantsCarlo Dani, Caterina Coviello, Fiorenza Panin, et al.
Seminars in Ophthalmology|March 19, 2024
Taser-Related Ocular Injuries: A Review of the Literature and Medico-Legal ImplicationsGiovanni Aulino, Federico Giannuzzi, Matteo Mario Carlà, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|March 27, 2020
Functional and Morphologic Findings at Four Years After Intravitreal Bevacizumab or Laser for Type 1 ROPDomenico Lepore, Marco H Ji, Graham E Quinn, et al.
International Journal of Legal Medicine|January 24, 2022
The role of retinal imaging in the management of abusive head trauma casesAntonio Oliva, Simone Grassi, Francesca Cazzato, et al.
Journal of Pediatric Ophthalmology and Strabismus|September 30, 2010
Effectiveness of ketorolac tromethamine in prevention of severe retinopathy of prematurityCarmen Giannantonio, Patrizia Papacci, Velia Purcaro, et al.
The Lancet. Child & Adolescent Health|August 15, 2021
2-year outcomes of ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW extension study): prospective follow-up of an open label, randomised controlled trialNeil Marlow, Andreas Stahl, Domenico Lepore, et al.
Journal of Applied Biomaterials & Functional Materials|February 7, 2017
Effect of topical antiinflammatory drugs on mechanical behavior of rabbit corneaDomenico Lepore, Roberto De Santis, Monica M Pagliara, et al.
Paediatric Anaesthesia|December 21, 2013
Phenylephrine eye drops in pediatric patients undergoing ophthalmic surgery: incidence, presentation, and management of complications during general anesthesiaFabio Sbaraglia, Nadia Mores, Rossella Garra, et al.
Ophthalmology. Retina|February 24, 2022
Time Course of Retinopathy of Prematurity Regression and Reactivation After Treatment with Ranibizumab or Laser in the RAINBOW TrialBrian W Fleck, James D Reynolds, Qi Zhu, et al.
Pageof 5